HR Execs on the Move

Cala Health

www.calahealth.com

 
Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company`s wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health`s wearable therapy is essential tremor, a disease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.calahealth.com
  • 1800 Gateway Drive Suite 300
    San Mateo, CA USA 94404
  • Phone: 415.890.3961

Executives

Name Title Contact Details
Maren Bean
Digital Product, Associate Director Profile
Deanna Harshbarger
Vice President of Product and Medical Affairs Profile

Similar Companies

Autism Treatment Centers

Autism Treatment Centers is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Dallas, TX. To find more information about Autism Treatment Centers, please visit www.atcoftexas.org

WithMe Health

WithMe Health replaces an employer`s pharmacy benefit manager (PBM) with a personalized medication guidance solution that greatly improves on and expands the scope of services available in the market today. Our modern technology and rich datasets allow consistent application of proven science to create individualized medication experiences for employees and their families that are proactive, adaptive, convenient and engaging. With an innovative, outcomes-oriented business model that aligns interests across the pharmaceutical value chain, WithMe Health optimizes health outcomes and value while substantially reducing costs for employers.

Versartis

Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.

Biolab

From our humble beginnings in Decatur, GA, in 1955, BioLab today is a leader in providing solutions for recreational and industrial water treatment and home cleaning. Our sales are now in excess of 600 million dollars annually and the stock of our parent

Emtech Laboratories Inc

Emtech Laboratories Inc is a Roanoke, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.